The study will include patients who are too young to be tested with spirometry, a conventional asthma measuring technique.

iSonea medical director Jonathan Freudman was quoted by proactiveinvestors as saying that in paediatric asthma population, it is challenging to monitor and manage asthma symptoms in patients using conventional techniques.

"The WheezoMeter has the potential to meet a critical unmet need for better, easy to use monitoring tools for young asthma patients," Freudman added.

WheezoMeter device utilizes company’s acoustic respiratory monitoring technology platform, which uses acoustic sensors and a signal processing software to establish the presence, frequency and severity of wheeze.

The device also records and analyses sounds caused by inflammation or narrowing of the airways, to quantify the rate of wheezing.